India's first Scorpene boat begins sea trials without primary weapons

Rahul Bedl

首页> 外文期刊>Jane's Defence Weekly >India's first Scorpene boat begins sea trials without primary weapons

【24h】

India's first Scorpene boat begins sea trials without primary weapons

机译：印度第一艘S鱼船在没有主要武器的情况下开始海上试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The first of six licence-built Kalvari (Scorpene)-class diesel-electric submarines for the Indian Navy (IN) began sea trials offMumbai's west coast on 1 May, ahead of being commissioned into service by the end of the year. The IN declared that Kalvari (Tiger Shark) sailed out to sea from the naval dockyard in Mumbai under its own propulsion and successfully validated preliminary tests on its propulsion system, auxiliary and communication equipment, navigational aids and steering gear.

机译：用于印度海军（IN）的六艘获得许可建造的卡尔瓦里（S鱼）级柴电潜艇中的第一艘于5月1日在孟买西海岸开始进行海上试验，然后于今年年底投入使用。以色列海军宣布，卡尔瓦里（虎鲨）在自己的推进力下从孟买的海军船坞出海，并成功验证了其推进系统，辅助和通信设备，导航辅助设备和舵机的初步测试。

著录项

来源
《Jane's Defence Weekly》 |2016年第19期|19-19|共1页
作者
Rahul Bedl;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial [J] . Cunningham David, Stenning Sally P., Smyth Elizabeth C., The lancet oncology . 2017,第3期

机译：无能为力的卵泡化疗中的化疗，可操作的卵泡癌腺癌（英国医学研究委员会ST03）：Multicentre，开放标签，随机阶段2-3试验的主要分析结果
2. Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in Type2 diabetic patients without established cardiovascular disease: Results from a randomized trial [J] . LadhaniN.N., MajumdarS.R., JohnsonJ.A., Diabetic medicine: A journal of the British Diabetic Association . 2012,第11期

机译：在初级保健团队中增加药剂师可降低没有确诊心血管疾病的2型糖尿病患者预期发生心血管事件的长期风险：一项随机试验的结果
3. Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803. [J] . Sargent D, Shi Q, Yothers G, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2011,第7期

机译：含氟嘧啶或不加奥沙利铂或伊立替康的三期辅助结肠癌试验以两年或三年无病生存（DFS）为主要终点：来自MOSAIC，X-ACT，PETACC-3，C- 06，C-07和C89803。
4. Comparative Analysis of Stern Ramp Sea Trials Results from a 154 ft Patrol Boat and a 418 ft Cutter [C] . Eric Schmid, William (Lew) Thomas, J. Ryan Roberts Launch and Recovery Symposium . 2014

机译：154英尺巡逻艇和418英尺切刀的船尾舷试航海结果的比较分析
5. Globalization of clinical research trials in India: Determining the quality of Indian clinical trials through the use of the Jadad scale [D] . Groesser, Kirsten J. 2010

机译：印度临床研究试验的全球化：通过使用Jadad量表确定印度临床试验的质量
6. Improving access to medicines for non-communicable diseases in rural primary care: results from a quasi-randomized cluster trial in a district in South India [O] . Manoj Kumar Pati, Upendra Bhojani, Maya Annie Elias, 2021

机译：改善农村初级保健中非传染性疾病的药物的获得：来自印度南部地区的准随机聚类试验结果
7. Manual aspiration versus chest tube drainage in primary spontaneous pneumothorax without underlying lung diseases: a meta-analysis of randomized controlled trials [O] . Pengzhi Zhu, Honggang Xia, Zhongyi Sun, 2019

机译：手动抽吸与胸管引流在初级自发性气胸患者无底层肺病：随机对照试验的荟萃分析

India's first Scorpene boat begins sea trials without primary weapons

摘要

著录项

相似文献

相关主题

期刊订阅